Suvorexant for alcohol use disorder and PTSD
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 65 years old.
- You need to have moderate to severe alcohol use disorder (AUD) and current PTSD symptoms that bother you.
- You must be motivated to cut back or stop drinking, and be willing to work on your PTSD.
- You should have trouble sleeping — a score of 7 or higher on the Insomnia Severity Index (ISI) questionnaire.
- You cannot be taking other sleep medications, and you must agree to avoid them during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the sleep medication suvorexant (Belsomra) can help people with opioid use disorder who also have trouble sleeping. If you are stable on medication for opioid use disorder and have not used opioids in the last month, this trial may be an option for you.
This study tests whether the sleep medication suvorexant can improve insomnia in veterans who also have post-traumatic stress disorder (PTSD). It aims to see if treating sleep helps with PTSD symptoms.
This study tests whether suvorexant, a sleep aid, can help people with alcohol use disorder by looking at brain changes. It may improve sleep and reduce drinking.
This study tests a new sleep medication (an orexin antagonist) to see if it helps Veterans with PTSD overcome fear and sleep better. It aims to improve how your brain handles fear responses.
This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.
This study tests a new sublingual (under-the-tongue) medication for people with alcohol use disorder who have also had a traumatic life event. It aims to see if the medication can help reduce drinking and related symptoms.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.